Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.
Indeed, one major draw of international stocks is that they look much cheaper compared with their U.S. counterparts. The S&P 500 traded at 22 times forward earnings as of Tuesday, while the STOXX 600 ...
Jefferies now values BABA’s cloud business at four times its revenue or about $60 billion, up from its previous estimate of ...
Alibaba, Futu, and Tencent all have strong potential. However, due to economic struggles and the Chinese government's influence, they are likely to be more volatile, so investors need to be aware of ...
Due to local regulations, Apple needs a Chinese partner to offer its AI services in China. It had been expected to work with ...
Apple sales have been struggling in China—iPhone revenue slumped 25% there in the fourth quarter—as the trade wars between ...
Asian equities were mostly higher overnight as Hong Kong and Indonesia outperformed while Taiwan and Pakistan underperformed.
Is Alibaba (BABA) finally prepared to capitalize on AI’s momentum worldwide? The company’s shares have rallied strongly since ...
The frenzy over Chinese artificial intelligence is turning Alibaba Group Holding Ltd. into an investor favorite again, ...
SMIC is the third-largest foundry globally, owning over 6% of the market in 2024, behind TSMC and Samsung; and overtaking GlobalFoundries and UMC. Intel is classified not as a foundry but as an ...
According to a recent report, Apple will not partner with DeepSeek for Apple Intelligence in China and will instead work with ...
We estimate that the 10% tariff the U.S. recently implemented on Chinese imports could create a 0.3-percentage point drag on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results